Cardiac Inflammation Research Group
11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Induction of murine experimental autoimmune myocarditis – technical details, implementation and evaluation
- Contribution to journal › Article
-
Mark
Marine-derived nutritional and bioactive compounds : Proteins and amino acids
(2025) p.263-298
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Development of novel neutralizing single-chain fragment variable antibodies against S100A8
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 inhibition reduces NADPH oxidase expression, reactive oxygen species production and NLRP3 inflammasome priming in the ischemic myocardium
- Contribution to journal › Article
- 2024
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
- Contribution to journal › Debate/Note/Editorial
-
Mark
A study of size-selective renal elimination using a novel human model
- Contribution to journal › Article
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
- Contribution to journal › Article
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
- Contribution to journal › Letter
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
